November 16, 2004JAMA
Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events
Why the study?
Does regression of electrocardiographic LVH during antihypertensive therapy reduce cardiovascular morbidity and mortality in persons with essential hypertension?
Population
Persons with essential hypertension
Authors
Discussion
Loading...
Member takes
Implication
Supports ECG LVH as independent prognostic marker in treated hypertension; leaves open whether regression is a modifiable therapeutic target.
Structured PICO
Does regression of electrocardiographic LVH during antihypertensive therapy reduce cardiovascular morbidity and mortality in persons with essential hypertension?
P
Population
Persons with essential hypertension
I
Intervention
Antihypertensive therapy resulting in less-severe electrocardiographic left ventricular hypertrophy (LVH)
O
Outcome
Cardiovascular morbidity and mortalityhard clinical
Regression of electrocardiographic LVH during antihypertensive therapy is an independent predictor of reduced cardiovascular morbidity and mortality.
Cite This Study
Peter M. Okin (2004) studied this question.